WHITEHAWK THERAPEUTICS, INC. Deferred Tax Assets, Investment in Subsidiaries
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Deferred Tax Assets, Investment in Subsidiaries of $0 as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInvestmentInSubsidiaries · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Investment in Subsidiaries $0.00.
- 2024-12-31: Deferred Tax Assets, Investment in Subsidiaries $34.11M.
- 2023-12-31: Deferred Tax Assets, Investment in Subsidiaries $0.00.
| Period end | Deferred Tax Assets, Investment in Subsidiaries |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2024-12-31 | $34.11M 10-K · filed 2026-03-12 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |